New Antibiotic Targets Drug-Resistant Gonorrhea

A partnership between GARDP and Debiopharm is advancing a promising new antibiotic to fight gonorrhea strains that no longer respond to existing treatments. This breakthrough could protect millions from a growing global health threat.